Healthcare -
Biotechnology - NASDAQ - US
$ 0.7132
1.86 %
$ 36.9 M
Market Cap
-1.04
P/E
XLO - CASH FROM OPERATIONS
Cash from Operations XLO - Xilio Therapeutics, Inc.
-18.4 M
LAST VALUE
50.74%
2 YEAR CAGR
-0.59%
5 YEAR CAGR
0.00%
10 YEAR CAGR